Health News

FDA Hepatitis Update - Pegasys and Copegus
On August 22, 2011, the FDA approved the combination of Pegasys and Copegus for the treatment of chronic hepatitis C virus ( HCV ) infection in pediatric patients 5 through 17 years of age.
Hepatitis B Vaccine for Pregnant Women
When women become pregnant, they often focus their energies on making sure their fetus is as healthy as possible. However, by delaying vaccination for hepatitis B (HBV) while pregnant, women may be putting their own health at risk.
Hepatitis C May Be Stopped Dead in its Tracks
Three percent of the world's population are infected with the hepatitis C virus, which is a leading cause of organ transplants, liver cancer and liver-related deaths.
Breakthrough Treatment With Incivek for Hepatitis C
It appears that a major breakthrough has occured in the treatment of a chronic liver disease. Remission looks to be a real possibility when telaprevir (Incivek) is combined with standard treatment for hepatitis C.
Hepatitis A Avoids the Immune System
Just when researchers were attributing hepatitis C's ability to become chronic was due to its superior ability to avoid the immune system, a new discovery was made. Hepatitis A can linger, too in the body for up to a year.
Hepatitis C Patients And Prevention
Along with an emerging mantra of improved health via diet and exercise, another emphasis should now be added: Prevention, in this case, prevention of hepatitis C.
coffee helps hepatitis c treatment response
"Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer," said Neal Freedman, PhD, MPH, of the National Cancer Institute and lead author of this study. "Although we observed an independent association between coffee intake and virologic response to treatment, this association needs replication in other studies." Among non-drinkers, 46 percent had an early virologic response; 26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20; 22 percent had no detectable...
Two New Hepatitis C Drugs Butt Marketing Heads
Hepatitis C virus (HCV) is an infectious disease which is 100 times more infectious than HIV. People who inject drugs or engage in unprotected sex account for most people who are infected with hepatitis C.
FDA approves Victrelis for Hepatitis C
The U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Victrelis is used for patients who still have some liver function, and who either have not been previously treated with drug therapy for their hepatitis C or who have failed such treatment. Victrelis is approved for use in combination with peginterferon alfa and ribavirin.
New Drug Mix for Hepatitis C
The current two-drug treatment for hepatitis C does not work as well as patients would like. Now, researchers have found that adding a third drug to the mix leads to better results.